• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bio-Rad Laboratories, Inc. Class A Common Stock (NY:BIO)

386.12 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Aug 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 386.12
Bid (Size) 369.00 (40)
Ask (Size) 613.93 (40)
Prev. Close 386.12
Today's Range 386.12 - 386.12
52wk Range 236.73 - 396.23
Shares Outstanding 22,140,000
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Bio-Rad to Participate in Fireside Chat During Wells Fargo’s 21st Annual Healthcare Conference
August 31, 2026
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Bio-Rad (BIO) Q2 2026 Earnings Call Transcript ↗
August 11, 2026
Digital PCR revenue surged over 20% as clinical diagnostics grew. 
Via The Motley Fool
Topics Earnings

Performance

YTD
+26.5%
+26.5%
1 Month
+15.4%
+15.4%
3 Month
+26.4%
+26.4%
6 Month
+38.1%
+38.1%
1 Year
+32.8%
+32.8%

More News

Read More
News headline image
Bio-Rad Laboratories Q2 Earnings Call Highlights ↗
August 05, 2026
Via MarketBeat
Topics Earnings
Bio-Rad (NYSE:BIO) Falls After Q2 Beat as Life Science Sales Weigh ↗
August 04, 2026
Via Chartmill
Bio-Rad Q1 2026 Revenue Misses Estimates, Outlook Cut as NYSE:BIO Faces Cautious Trading ↗
April 30, 2026
Via Chartmill
Bio-Rad Laboratories (NYSE:BIO) Stock Plummets 12% After Q4 Earnings Miss and Weak 2026 Outlook ↗
February 12, 2026
Via Chartmill
Topics Earnings
News headline image
Earnings Scheduled For October 29, 2025 ↗
October 29, 2025
Via Benzinga
News headline image
Bio-Rad Reports Second-Quarter 2026 Financial Results
August 04, 2026
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Bio-Rad to Report Second-Quarter 2026 Financial Results on Tuesday, August 4, 2026
July 23, 2026
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Bio-Rad vs. Charles River Labs: Which Medical Research Stock Is a Better Buy in 2026? ↗
June 22, 2026
Via The Motley Fool
News headline image
Why Elliott Sees Hidden Billions Inside Bio-Rad Laboratories ↗
May 18, 2026
Via Benzinga
News headline image
Bio-Rad to Participate in Upcoming Investor Conferences
May 08, 2026
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Bio-Rad (BIO) Q2 2025 Earnings Call Transcript ↗
May 04, 2026
Via The Motley Fool
Topics Earnings
News headline image
Bio-Rad (BIO) Q1 2026 Earnings Transcript ↗
May 01, 2026
Via The Motley Fool
Topics World Trade
News headline image
Bio-Rad Reports First-Quarter 2026 Financial Results
April 30, 2026
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Bio-Rad to Report First-Quarter 2026 Financial Results on Thursday, April 30, 2026
April 16, 2026
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Bio-Rad (BIO) Q4 2025 Earnings Call Transcript ↗
February 12, 2026
Via The Motley Fool
Topics Earnings
News headline image
Bio-Rad Reports Fourth-Quarter and Full-Year 2025 Financial Results
February 12, 2026
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Bio-Rad to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 12, 2026
January 29, 2026
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan's 44th Annual Healthcare Conference
January 06, 2026
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Why a Fund Trimmed a $41 Million CompoSecure Stake Amid a 47% Stock Run ↗
December 23, 2025
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why a Fund Cut $4 Million of Payoneer Stock Despite Record Revenues ↗
December 23, 2025
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why Bio-Rad Laboratories Stock Slipped by More Than 3% on Thursday ↗
October 30, 2025
Via The Motley Fool
Topics Supply Chain
News headline image
Bio-Rad Reports Third-Quarter 2025 Financial Results
October 29, 2025
From Bio-Rad Laboratories, Inc.
Via Business Wire
News headline image
Bio-Rad to Report Third Quarter 2025 Financial Results on Wednesday, October 29, 2025
October 16, 2025
From Bio-Rad Laboratories, Inc.
Via Business Wire

Frequently Asked Questions

Is Bio-Rad Laboratories, Inc. Class A Common Stock publicly traded?
Yes, Bio-Rad Laboratories, Inc. Class A Common Stock is publicly traded.
What exchange does Bio-Rad Laboratories, Inc. Class A Common Stock trade on?
Bio-Rad Laboratories, Inc. Class A Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Bio-Rad Laboratories, Inc. Class A Common Stock?
The ticker symbol for Bio-Rad Laboratories, Inc. Class A Common Stock is BIO on the New York Stock Exchange
What is the current price of Bio-Rad Laboratories, Inc. Class A Common Stock?
The current price of Bio-Rad Laboratories, Inc. Class A Common Stock is 386.12
When was Bio-Rad Laboratories, Inc. Class A Common Stock last traded?
The last trade of Bio-Rad Laboratories, Inc. Class A Common Stock was at 08/31/26 07:00 PM ET
What is the market capitalization of Bio-Rad Laboratories, Inc. Class A Common Stock?
The market capitalization of Bio-Rad Laboratories, Inc. Class A Common Stock is 8.55B
How many shares of Bio-Rad Laboratories, Inc. Class A Common Stock are outstanding?
Bio-Rad Laboratories, Inc. Class A Common Stock has 9B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap